
Mathew Williams
System Head, CVI Structural Heart Disease Program · NYU Grossman School of Medicine
Credentials: · · · ·
History
PresentCVI Structural Heart Disease Program Division · NYU Grossman School of Medicine
PresentNYU Langone Heart · NYU Grossman School of Medicine

- 2007–2008
- 2006–2007
2005–2006


Research
Transcatheter versus surgical aortic-valve replacement in high-risk patients
New England Journal of Medicine · 2011 · 5,229 citations
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
New England Journal of Medicine · 2016 · 4,142 citations
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
New England Journal of Medicine · 2019 · 3,979 citations

90 papers
- SK
87 papers · 1 as a fellow

54 papers · 1 as a fellow

54 papers

49 papers

47 papers
- RM
46 papers

42 papers
Clinical trials
- 2021–2031
- 2017–2023
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
Principal investigator · Terminated
HLT Inc.
- 2016–2021
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Principal investigator · Completed
Medtronic Cardiovascular
- 2016–2021


